Clinical trial
Double Blind, Randomised, Cross-over Study Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects
NCT01370486 is registered in ClinicalTrials.gov with Institution de Lavigny as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind, Randomised, Cross-over Study Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects
- Lead sponsor
- Institution de Lavigny
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- August 31, 2011
- Completion date
- January 31, 2012
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lennox-gastaut syndrome